Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Charmsaz

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Oncotarget|November 16, 2017
Eph receptors as oncotargetsSara Charmsaz, Andrew W Boyd
Experimental Hematology|July 29, 2017
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptorsSara Charmsaz, Andrew M Scott, Andrew W Boyd
Cancer Gene Therapy|December 20, 2022
Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancerPreeti Borde, Nicola Cosgrove, Sara Charmsaz, et al.
Cancers|August 10, 2019
Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual ConferenceSara Charmsaz, Denis M Collins, Antoinette S Perry, et al.
Cancer Gene Therapy|November 9, 2022
An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancerPreeti Borde, Nicola Cosgrove, Sara Charmsaz, et al.
Cancers|June 21, 2018
Innovative Technologies Changing Cancer TreatmentSara Charmsaz, Maria Prencipe, Maeve Kiely, et al.
Plos One|June 18, 2015
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaSara Charmsaz, Kirrilee Beckett, Fiona M Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2021
Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine TherapyRachel Bleach, Stephen F Madden, James Hawley, et al.
Oncogene|December 16, 2020
Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κBManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
BMC Medicine|April 13, 2017
S100β as a serum marker in endocrine resistant breast cancerSara Charmsaz, Éamon Hughes, Fiona T Bane, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Oncotarget|November 16, 2017
Eph receptors as oncotargetsSara Charmsaz, Andrew W Boyd
Experimental Hematology|July 29, 2017
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptorsSara Charmsaz, Andrew M Scott, Andrew W Boyd
Cancer Gene Therapy|December 20, 2022
Correction to: An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancerPreeti Borde, Nicola Cosgrove, Sara Charmsaz, et al.
Cancers|August 10, 2019
Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual ConferenceSara Charmsaz, Denis M Collins, Antoinette S Perry, et al.
Cancer Gene Therapy|November 9, 2022
An investigation of Sigma-1 receptor expression and ligand-induced endoplasmic reticulum stress in breast cancerPreeti Borde, Nicola Cosgrove, Sara Charmsaz, et al.
Cancers|June 21, 2018
Innovative Technologies Changing Cancer TreatmentSara Charmsaz, Maria Prencipe, Maeve Kiely, et al.
Plos One|June 18, 2015
EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaSara Charmsaz, Kirrilee Beckett, Fiona M Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2021
Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine TherapyRachel Bleach, Stephen F Madden, James Hawley, et al.
Oncogene|December 16, 2020
Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κBManikandan Periyasamy, Anup K Singh, Carolina Gemma, et al.
BMC Medicine|April 13, 2017
S100β as a serum marker in endocrine resistant breast cancerSara Charmsaz, Éamon Hughes, Fiona T Bane, et al.
Pageof 2